Literature DB >> 35369653

New Vancomycin Dosing Guidelines for Hemodialysis Patients: Rationale, Caveats, and Limitations.

Susan J Lewis1, Thomas D Nolin2.   

Abstract

Entities:  

Keywords:  hemodialysis; nephro-pharmacology; patients; vancomycin

Mesh：

Substances：

Year:  2021        PMID： 35369653      PMCID： PMC8676380          DOI： 10.34067/KID.0000192021

Source DB:  PubMed          Journal:  Kidney360        ISSN： 2641-7650


× No keyword cloud information.
  10 in total

Review 1.  Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists.

Authors:  Michael Rybak; Ben Lomaestro; John C Rotschafer; Robert Moellering; William Craig; Marianne Billeter; Joseph R Dalovisio; Donald P Levine
Journal:  Am J Health Syst Pharm       Date:  2009-01-01       Impact factor: 2.637

2.  Are vancomycin trough concentrations adequate for optimal dosing?

Authors:  Michael N Neely; Gilmer Youn; Brenda Jones; Roger W Jelliffe; George L Drusano; Keith A Rodvold; Thomas P Lodise
Journal:  Antimicrob Agents Chemother       Date:  2013-10-28       Impact factor: 5.191

3.  Vancomycin Area Under the Curve and Acute Kidney Injury: A Meta-analysis.

Authors:  Doaa M Aljefri; Sean N Avedissian; Nathaniel J Rhodes; Michael J Postelnick; Kevin Nguyen; Marc H Scheetz
Journal:  Clin Infect Dis       Date:  2019-11-13       Impact factor: 9.079

4.  Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists.

Authors:  Michael J Rybak; Jennifer Le; Thomas P Lodise; Donald P Levine; John S Bradley; Catherine Liu; Bruce A Mueller; Manjunath P Pai; Annie Wong-Beringer; John C Rotschafer; Keith A Rodvold; Holly D Maples; Benjamin M Lomaestro
Journal:  Am J Health Syst Pharm       Date:  2020-05-19       Impact factor: 2.637

5.  A Quasi-Experiment To Study the Impact of Vancomycin Area under the Concentration-Time Curve-Guided Dosing on Vancomycin-Associated Nephrotoxicity.

Authors:  Natalie A Finch; Evan J Zasowski; Kyle P Murray; Ryan P Mynatt; Jing J Zhao; Raymond Yost; Jason M Pogue; Michael J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2017-11-22       Impact factor: 5.191

6.  Practical vancomycin dosing in hemodialysis patients in the era of emerging vancomycin resistance: a single-center experience.

Authors:  Maria E Taylor; Michael Allon
Journal:  Am J Kidney Dis       Date:  2010-06       Impact factor: 8.860

7.  Staphylococcus aureus resistant to vancomycin--United States, 2002.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2002-07-05       Impact factor: 17.586

8.  Antimicrobial use in outpatient hemodialysis units.

Authors:  Graham M Snyder; Priti R Patel; Alexander J Kallen; James A Strom; J Kevin Tucker; Erika M C D'Agata
Journal:  Infect Control Hosp Epidemiol       Date:  2013-02-18       Impact factor: 3.254

9.  The ratio of pre-dialysis vancomycin trough serum concentration to minimum inhibitory concentration is associated with treatment outcomes in methicillin-resistant Staphylococcus aureus bacteremia.

Authors:  Chien-Fang Fu; Jiun-Da Huang; Jann-Tay Wang; Shu-Wen Lin; Chien-Chih Wu
Journal:  PLoS One       Date:  2018-03-05       Impact factor: 3.240

10.  Evaluation and Development of Vancomycin Dosing Schemes to Meet New AUC/MIC Targets in Intermittent Hemodialysis Using Monte Carlo Simulation Techniques.

Authors:  Susan J Lewis; Bruce A Mueller
Journal:  J Clin Pharmacol       Date:  2020-08-26       Impact factor: 3.126
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.